Discover 55 paid clinical trials in Bismarck, North Dakota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 55
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
for
Extensive Stage Lung Small Cell Carcinoma,
Location: Bismarck ND, Fargo ND, Bemidji MN, Sioux Falls SD,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06769126
Phase 2, Recruiting
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia
Location: Bismarck ND, Aberdeen SD, Pierre SD, Fargo ND,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 65+
Code: NCT07321652
Phase 3, Recruiting
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Location: Bismarck ND, Fargo ND, Bemidji MN, Sioux Falls SD,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT06958328
Phase 3, Recruiting
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
for
Pancreatic Neoplasm
Location: Bismarck ND, Fargo ND, Thief River Falls MN, Bemidji MN,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 50 - 70+
Code: NCT04239573
Recruiting
E-Mindfulness Approaches for Living After Breast Cancer
for
Breast Cancer, Depression
Location: Bismarck ND, Fargo ND, Rapid City SD, Sioux Falls SD,
Sponsor: NRG Oncology
Sex: All
Age: 18 - 50
Code: NCT06748222
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
for
Head and Neck Squamous Cell Carcinoma,
Location: Bismarck ND, Fargo ND, Bemidji MN, Sioux Falls SD,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06992427
Phase 3, Recruiting
General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care Delivery
for
Type 1 Diabetes, Celiac Disease
Location: Bismarck ND, Fargo ND, Bemidji MN, Sioux Falls SD
Sponsor: Sanford Health
Sex: All
Age: 0 - 17
Code: NCT04477928
Recruiting
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
for
Advanced Malignant Solid Neoplasm,
Location: Bismarck ND, Fargo ND, Rapid City SD, Bemidji MN,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0+
Code: NCT05564377
Phase 2, Recruiting
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers
for
Metastatic Salivary Gland Carcinoma,
Location: Bismarck ND, Fargo ND, Bemidji MN, Sioux Falls SD,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT05408845
Phase 2, Recruiting
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Bismarck ND, Fargo ND, Bemidji MN, Sioux Falls SD,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 0+
Code: NCT06031688
Phase 2, Recruiting
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
for
Acute Myeloid Leukemia,
Location: Bismarck ND, Fargo ND, Winnipeg, Bemidji MN,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05564390
Phase 2, Recruiting
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
for
Recurrent Lung Non-Small Cell Carcinoma,
Location: Bismarck ND, Fargo ND, Rapid City SD, Bemidji MN,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06616584
Phase 2, Phase 3, Recruiting
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
for
Metastatic Renal Cell Carcinoma,
Location: Bismarck ND, Fargo ND, Bemidji MN, Sioux Falls SD,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT05327686
Phase 2, Recruiting
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Bismarck ND, Fargo ND, Bemidji MN, Sioux Falls SD,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05987241
Phase 2, Phase 3, Recruiting
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
for
Pancreatic Acinar Cell Carcinoma,
Location: Bismarck ND, Aberdeen SD, Pierre SD, Fargo ND,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04858334
Phase 2, Recruiting
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
for
Colorectal Cancer, Sarcopenia
Location: Bismarck ND, Fargo ND, Detroit Lakes MN, Park Rapids MN,
Sponsor: Wake Forest University Health Sciences
Sex: All
Age: 60+
Code: NCT03998202
Recruiting
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Bismarck ND, Fargo ND, Thief River Falls MN, Bemidji MN,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 0+
Code: NCT04242095
Recruiting
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
for
Mantle Cell Lymphoma
Location: Bismarck ND, Fargo ND, Bemidji MN, Sioux Falls SD,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 60+
Code: NCT05976763
Phase 3, Recruiting
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer